Top banner
MY AMERICAN SCIENTIST
LOG IN! REGISTER!
SEARCH
 
RSS
Logo

SCIENCE IN THE NEWS DAILY

In Study, Drug Delays Worsening of Breast Cancer, With Fewer Side Effects

from the New York Times (Registration Required)

CHICAGO -- A drug that delivers a powerful poison to tumors without some of the side effects of traditional treatments can delay the worsening of breast cancer and also appears to substantially prolong lives, according to results of a study presented here [the American Society of Clinical Oncology] Saturday.

Besides representing an advance in treating breast cancer, the success in the clinical trial validates an idea that is now being pursued by numerous pharmaceutical companies to treat various types of cancer in a way that delivers drugs to cancerous cells while sparing healthy ones.

"We've envisioned a world where cancer treatment would kill the cancer and not hurt the patient," Dr. Kimberly L. Blackwell, a professor of medicine at the Duke Cancer Institute and the lead investigator in the trial, said in an interview. "And this drug does that."

Read more...

 

EMAIL TO A FRIEND :


Bottom Banner